StockData
AEON Biopharma, Inc. logo

AEON Biopharma, Inc. (AEON) stock

AEONNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 4/30
$0.15−0.01 (-3.59%)

Close on Nov 13, 2026Market cap $7.63MP/E –Yield –

AEON Biopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

AEON Biopharma's EV/EBITDA was 0.0× on Apr 30, 2025.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20250.0×–

More AEON Biopharma figures

See a number that looks wrong?